BR9812791A - Sequências de ácido nucléico associadas à virulência e seu uso - Google Patents

Sequências de ácido nucléico associadas à virulência e seu uso

Info

Publication number
BR9812791A
BR9812791A BR9812791-8A BR9812791A BR9812791A BR 9812791 A BR9812791 A BR 9812791A BR 9812791 A BR9812791 A BR 9812791A BR 9812791 A BR9812791 A BR 9812791A
Authority
BR
Brazil
Prior art keywords
nucleic acid
virulence
acid sequences
polypeptides
sequences associated
Prior art date
Application number
BR9812791-8A
Other languages
English (en)
Inventor
Frederick Ausubeu
Howard M Goodman
Laurence G Rahme
Shalina Mahajan-Miklos
Man-Wah Tan
Hui Cao
Eliana Drenkard
John Tsongalis
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of BR9812791A publication Critical patent/BR9812791A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Abstract

Patente de Invenção: <B>"SEQuêNCIAS DE áCIDO NUCLéICO ASSOCIADAS à VIRULêNCIA E SEU USO"<D>. São descritos polipeptídios de virulência bacteriana e seq³ências de ácido nucléico (por exemplo, DNA) codificando tais polipeptídios, e métodos para a produção de tais polipeptídios através de técnicas recombinantes. Também são providos métodos para a utilização de tais polipeptídios para o exame de compostos antibacterianos e bacteriostáticos.
BR9812791-8A 1997-11-25 1998-11-25 Sequências de ácido nucléico associadas à virulência e seu uso BR9812791A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6651797P 1997-11-25 1997-11-25
PCT/US1998/025247 WO1999027129A1 (en) 1997-11-25 1998-11-25 Virulence-associated nucleic acid sequences and uses thereof

Publications (1)

Publication Number Publication Date
BR9812791A true BR9812791A (pt) 2000-10-17

Family

ID=22070007

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812791-8A BR9812791A (pt) 1997-11-25 1998-11-25 Sequências de ácido nucléico associadas à virulência e seu uso

Country Status (12)

Country Link
US (3) US6355411B1 (pt)
EP (1) EP1040200A4 (pt)
JP (1) JP2002505849A (pt)
KR (1) KR20010032432A (pt)
CN (1) CN1309720A (pt)
AU (1) AU763126B2 (pt)
BR (1) BR9812791A (pt)
CA (1) CA2310561A1 (pt)
HU (1) HUP0100668A3 (pt)
IL (1) IL136349A0 (pt)
NZ (1) NZ504669A (pt)
WO (1) WO1999027129A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756493B1 (en) * 1998-09-01 2004-06-29 Antex Biologics, Inc. Nucleic acid sequence and uses thereof
US6693186B2 (en) * 1998-09-01 2004-02-17 Antex Biologics Inc Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
EP2382982A3 (en) * 2001-08-24 2012-02-22 Neuren Pharmaceuticals Limited Neural regeneration peptide and methods for their use in treatment of brain damage
US20050119302A1 (en) * 2001-10-30 2005-06-02 Rahme Laurence G. Methods for the prevention or treament of bacterial and fungal infections
AU2003272339A1 (en) * 2002-09-12 2004-04-30 The General Hospital Corporation Virulence-associated nucleic acids and proteins and uses thereof
US8445639B2 (en) * 2006-05-15 2013-05-21 Avidbiotics Corporation Recombinant bacteriophage and methods for their use
DK2021358T3 (da) * 2006-05-15 2012-07-16 Avidbiotics Corp Modificerede bakteriociner og fremgangsmåder til anvendelse af disse
US7700729B2 (en) * 2006-05-15 2010-04-20 Avidbiotics Corporation Modified bacteriocins and methods for their use
EP2166769B1 (en) 2007-06-29 2017-04-05 Sharp Kabushiki Kaisha Image encoding device, image encoding method, image decoding device, image decoding method, program, and recording medium
CA2732305A1 (en) * 2008-07-30 2010-02-04 General Electric Company Method for evaluating the virulence of pathogenic biphasic bacteria
US9237327B2 (en) * 2008-09-23 2016-01-12 Dolby Laboratories Licensing Corporation Encoding and decoding architecture of checkerboard multiplexed image data
US10406211B2 (en) 2011-04-25 2019-09-10 California Institute Of Technology Methods and system for interfering with viability of bacteria and related compounds and compositions
US9926526B2 (en) * 2011-04-25 2018-03-27 California Institute Of Technology Methods and system for interfering with viability of bacteria and related compounds and compositions
CN117462693A (zh) 2012-02-27 2024-01-30 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
US9334542B2 (en) * 2012-04-02 2016-05-10 Life Technologies Corporation Compositions and methods for detection of microorganisms of the Mycobacterium avium complex excluding Mycobacterium avium paratuberculosis
WO2013151647A1 (en) 2012-04-02 2013-10-10 Life Technologies Corporation Compositions and methods for detection of mycobacterium avium paratuberculosis
US10913936B2 (en) 2016-03-22 2021-02-09 California Institute Of Technology Phenazine degrading agents and related compositions, methods and systems for interfering with viability of bacteria

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0411897A (ja) * 1989-10-04 1992-01-16 Sumitomo Chem Co Ltd 抗緑膿菌外毒素ａヒトモノクローナル抗体
US6461854B1 (en) * 1995-03-28 2002-10-08 The General Hospital Corporation Methods of screening compounds useful for prevention of infection or pathogenicity
US7166270B1 (en) 1995-03-28 2007-01-23 The Netherlands Cancer Institute Methods of screening compounds useful for prevention of infection or pathogenicity
US5994066A (en) 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
GB9608000D0 (en) 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607993D0 (en) 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607991D0 (en) 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9619072D0 (en) 1996-09-12 1996-10-23 Smithkline Beecham Plc Novel compounds
US6004556A (en) 1996-10-24 1999-12-21 Smithkline Beecham Corporation Staphylococcus aureus RSBU-1
US5827689A (en) 1996-11-13 1998-10-27 Smithkline Beecham Corporation FabD polynucleotides

Also Published As

Publication number Publication date
HUP0100668A3 (en) 2005-01-28
CN1309720A (zh) 2001-08-22
KR20010032432A (ko) 2001-04-25
JP2002505849A (ja) 2002-02-26
US20070105167A1 (en) 2007-05-10
AU763126B2 (en) 2003-07-10
US20030022349A1 (en) 2003-01-30
IL136349A0 (en) 2001-05-20
EP1040200A1 (en) 2000-10-04
US6355411B1 (en) 2002-03-12
AU1799699A (en) 1999-06-15
NZ504669A (en) 2002-11-26
CA2310561A1 (en) 1999-06-03
HUP0100668A2 (hu) 2001-06-28
WO1999027129A1 (en) 1999-06-03
EP1040200A4 (en) 2005-04-20

Similar Documents

Publication Publication Date Title
BR9812791A (pt) Sequências de ácido nucléico associadas à virulência e seu uso
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
ES2134770T3 (es) Proteinas producidas por los linfocitos humanos, secuencia de adn codante para estas proteinas y aplicaciones farmaceuticas y biologicas.
EP1288299A3 (en) TRNA synthetase
EP1275720A3 (en) Histidyl-trna synthetase of staphylococcus aureus
ES2142953T3 (es) Factor de crecimiento y diferenciacion de la familia del tgf-beta.
DE69327645D1 (de) Dna-sequenzen kodierend für neuartige wachstums-/differentierungsfaktoren
EP1260587A3 (en) Tyrosyl tRNA synthetase
FI945221A (fi) Yhdistelmä-DNA-molekyylejä, jotka koodittavat aminopeptidaasientsyymejä, ja niiden käyttö rokotteiden valmistamiseksi matotartuntoja vastaan
DE506574T1 (de) Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
GB0202556D0 (en) Novel Protein
FR2723951B1 (fr) Peptide, agent antibacterien contenant ce peptide, gene de ce peptide, adn recombine contenant ce gene et procede de preparation de ce peptide.
DK0445971T3 (da) DNA, som koder for et hoved-mideallergen, og anvendelse heraf
ATE253113T1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
WO2001046260A3 (en) Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof
FI961202A (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
NO922421L (no) Collagenbindende protein, samt fremstilling derav
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
PT816504E (pt) Acetil-hidrolase para o factor activador das plaquetas, e seu gene
DE69934415D1 (de) Neuartiges collectin
EP0854186A3 (en) Staphylococcus aureus cell division gene DivIB
ATE412753T1 (de) Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür
BR9915537A (pt) Gene prv-1 e sua utilização
CA2244928A1 (en) Dna coding for serine/threonine kinase
CA2188264A1 (en) Isolated nucleic acid molecule coding for fibroblast activation protein .alpha. and uses thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1890 DE 27/03/2007.